Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia MA Omair, FK AlDuraibi, MK Bedaiwi, S Abdulaziz, W Husain, ... Clinical Rheumatology 36, 1537-1543, 2017 | 25 | 2017 |
Lupus nephritis correlates with B cell interferon-β, anti-Smith, and anti-DNA: a retrospective study F Alduraibi, H Fatima, JA Hamilton, WW Chatham, HC Hsu, JD Mountz Arthritis Research & Therapy 24 (1), 87, 2022 | 14 | 2022 |
Host genetics but not commensal microbiota determines the initial development of systemic autoimmune disease in BXD2 mice H Hong, F Alduraibi, D Ponder, WL Duck, CD Morrow, JB Foote, ... Arthritis & Rheumatology 74 (4), 634-640, 2022 | 12 | 2022 |
Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis SM Al-Mukhaini, H Al-Eid, F Alduraibi, HI Hakami, H Al Talhi, M Shoukri, ... Annals of Saudi Medicine 37 (2), 138, 2017 | 12 | 2017 |
Clustering patients with gout based on comorbidities and biomarkers: a cross-sectional study FK Alduraibi, M Saleem, K Ricart, RP Patel, AJ Szalai, JA Singh The Journal of Rheumatology 50 (6), 817-826, 2023 | 10 | 2023 |
Lupus nephritis biomarkers: a critical review FK Alduraibi, GC Tsokos International Journal of Molecular Sciences 25 (2), 805, 2024 | 8 | 2024 |
IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient JD Mountz, M Gao, DM Ponder, S Liu, CW Sun, F Alduraibi, K Sullivan, ... Clinical Immunology, 2022 | 8 | 2022 |
Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: A cross-sectional study FK Alduraibi, KA Sullivan, WW Chatham, HC Hsu, JD Mountz Clinical Immunology 247, 109239, 2023 | 7 | 2023 |
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits FK Alduraibi, JA Singh Current Rheumatology Reports 25 (12), 295-306, 2023 | | 2023 |
Increased development of T-bet+ CD11c+ B cells predisposes to lupus in females: Analysis in BXD2 mouse and genetic crosses KA Sullivan, C Chapman, L Lu, DG Ashbrook, Y Wang, FK Alduraibi, C Lu, ... Clinical Immunology 257, 109842, 2023 | | 2023 |
Thank you to the reviewers of Rheumatology M Bukhari Rheumatology 62 (8), 2639-2645, 2023 | | 2023 |
Interrelation of T-cell Cytokines and Autoantibodies in Lupus Nephritis: A Cross-sectional Study F Alduraibi, K Sullivan, WW Chatham, HC Hsu, JD Mountz | | 2022 |
Distinct Clinical Manifestations Associated with Autoantibodies and Cytokines in Systemic Lupus Erythematosus F Alduraibi ProQuest Dissertations & Theses Global, 2022 | | 2022 |
2022 Western Medical Research Conference E Batton, S Laies, K Vo, S Bukhari, C Fateri, A Freifeld, D Mesa J Investig Med 70, 110-345, 2022 | | 2022 |
Clustering Patients with Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study F Alduraibi, R Saleem, Mohammad, P Karina, S Rakesh, S Alexander, ... The 13th European Crystal Workshop, https://www.european-crystal-network.com, 2022 | | 2022 |
B-CELL INTERFERON-b CORRELATES WITH LUPUS NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS FK Alduraibi, H Fatima, W Chatham, H Hsu, J Mountz JOURNAL OF INVESTIGATIVE MEDICINE 70 (1), 321-321, 2022 | | 2022 |
510 B-cell interferon-β correlates with lupus nephritis in systemic lupus erythematosus F Alduraibi, H Fatima, JA Hamilton, WW Chatham, HC Hsu, JD Mountz Lupus Science & Medicine 8 (Suppl 2), 2021 | | 2021 |
Role of B-cell endogenous interferon beta in lupus nephritis FK Alduraibi, HC Hsu, H Fatima, WW Chatham, JD Mountz The Journal of Immunology 206 (1_Supplement), 52.13-52.13, 2021 | | 2021 |
B Cell Intracellular IFNβ as a Unique Cellular Marker for the Development of Lupus Nephritis F Alduraibi, H Fatima, W Chatham, HC Hsu, J Mountz ARTHRITIS & RHEUMATOLOGY, 2021 | | 2021 |
Endogenous Interferon-beta and Low IL-4R on Transitional B Cells Promotes Lupus Nephritis F Alduraibi, H Fatima, WW Chatham, HC Hsu, J Mountz ARTHRITIS & RHEUMATOLOGY 72, 2020 | | 2020 |